WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
SINGAPORE, June 5, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has completed the topping out of the Drug Product (DP) facility at its Singapore CRDMO Hub (Hub). Once operational, the facility will be the Company's key DP facility designed to meet the latest and most stringent requirements...
Herbalgy “TO-Go” Summer Treat: Keung To-Themed Gelato Truck
Free Gelato + Exclusive Fan Support Hand Fan, Stay Cool. Stay "TO". One Receipt, Triple Summer Rewards: Win The Herbalgy Trophy Tickets! HONG KONG, June 5, 2026 /PRNewswire/ -- Summer is heating up across the city! With FIFA World Cup fever sweeping the globe and the Hong Kong Football Festival 2026 in full swing,...
VARON Shares Essential Summer Travel and Safety Tips for Oxygen Concentrator Users
NEW YORK, June 5, 2026 /PRNewswire/ -- As summer travel season approaches, millions of Americans are preparing for vacations, family visits, road trips, and outdoor activities. For individuals who depend on oxygen therapy, a little preparation can go a long way toward ensuring a safe, comfortable, and enjoyable journey. VARON Oxygen Concentrator is highlighting practical summer travel tips...
Osara Health Expands Into Survivorship Care, Strengthening Cancer Support Beyond Treatment
The expanded Cancer Coach program introduces new survivorship modules building on the latest outcomes showing a 25:1 ROI and ~66% of participants improved physical and mental health. NEW YORK, June 5, 2026 /PRNewswire/ -- Osara Health, a global digital health company focused on providing support for the human experience of cancer, today...
Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing
OXFORD, United Kingdom and HOUSTON, June 5, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more than 3 million cases to date. This milestone underscores Optellum's commitment to empowering health systems and clinical care teams with the...
Natural Field Announces New Cartilage Health Research Findings Ahead of CPHI China 2026
XI'AN, China, June 4, 2026 /PRNewswire/ -- Natural Field recently completed a Phase I scientific evaluation study on joint health functionality. The results demonstrated that glucosamine-chondroitin co-loading liposomes exhibited significant activity in a cartilage injury repair model, providing new scientific evidence for product innovation in joint health, sports nutrition, and healthy...
Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics
New Frost & Sullivan White Paper Highlights Emerging Opportunities Across Healthy Aging, Functional Nutrition, Personal Care, and Preventive Healthcare SHANGHAI, June 4, 2026 /PRNewswire/ -- Frost & Sullivan's latest white paper, Global Ergothioneine Industry Current Landscape and Development Trends, reveals that ergothioneine (EGT) is rapidly transitioning from a niche antioxidant ingredient into a scalable, science-backed platform for health and wellness...
Soonr Health Officially Launches in the U.S. with Connected At-Home Fertility Tracking for Couples
With the launch of Surearly SMART on Amazon, Soonr Health now offers couples connected at-home ovulation and hormone testing, the first device in an expanding ecosystem built around dyadic health. SEOUL, South Korea, June 4, 2026 /PRNewswire/ -- Vespexx Inc., a femtech company building products around the science of dyadic health, today announced the official U.S. launch of Soonr...
Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day
WuXi XDC and BioDlink jointly hosted the 2026 Open Day, marking their first flagship customer-facing event following the strategic integration. The event brought together biotech customers, industry leaders and innovators to explore how an integrated ADC/XDC CRDMO platform can accelerate the development and commercialization of next-generation bioconjugate therapies. SUZHOU, China, June 4, 2026 /PRNewswire/ -- WuXi...
PharmaBlock’s First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now Operational
Next-Generation Peptide CRDMO Solutions Enabled by a Green and Intelligent Platform for Empowering Global Innovative Drug Development NANJING, China, June 4, 2026 /PRNewswire/ -- PharmaBlock Sciences (Stock Code: 300725.SZ) today announced the commissioning of its first peptide pilot-scale GMP plant at PharmaBlock Zhejiang manufacturing site. As early-stage development programs of peptides and their conjugates...
